Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Preprints

Date Submitted: Oct 24, 2023

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

ACT Vet: A mixed-methods pilot study of efficacy, usability and cost-effectiveness of an Acceptance and Commitment Therapy (ACT) based app for veterans with harmful gambling and PTSD

  • Catherine Hitch; 
  • Dan Leightley; 
  • Dominic Murphy; 
  • Simon Dymond

ABSTRACT

Background:

Acceptance and Commitment Therapy (ACT) may be beneficial for veterans experiencing harmful gambling and co-occurring mental health issues. Psychological treatment and support based on ACT is gaining popularity in the digital health domain and has the potential to widen access for vulnerable groups. Although ACT and gambling apps exist, respectively, there is currently an absence of eHealth tools for veterans with harmful gambling and related comorbidities such as post-traumatic stress disorder (PTSD).

Objective:

This mixed-methods pilot intervention will create and test a digital health-based ACT app (ACT Vet) for veterans with experience of harmful gambling and PTSD. The intervention is 12 weeks’ duration. App testing will assess efficacy, usability, and cost-effectiveness through self-report measures and detailed interviews.

Methods:

A smartphone app will deliver ACT via a structured manual of six modules (steps), each centred on one of ACT’s core components. Combined, the six steps aim to encourage psychological flexibility and diminish the impact, and likelihood of, harmful gambling. The pilot study will include UK Armed Forces veterans recruited via a range of methods, while consent and data collection will occur within the app. Data is collected at five time points (baseline, weeks 3, 6, 9, 12). The primary outcome is altered gambling harm scores between baseline and week 12, with secondary outcomes relating to psychological flexibility, changes in mental health, quality of life, and gambling-related financial costs. Process evaluation includes general app use and mHealth App Usability Questionnaire scores. Qualitative data, related to real-time app use and general feedback, will be subject to thematic analysis.

Results:

Pilot recruitment will commence in February 2024 and continue for five months. Analysis and dissemination will occur between July and December 2024.

Conclusions:

This study will examine the efficacy, usability, and cost-effectiveness of ACT Vet; a manualised gambling app, for veterans with co-occurring harmful gambling and PTSD. Potential findings from ACT Vet may determine whether an eHealth tool can have cost-saving benefits for veterans, members of the general population, and UK statutory gambling and mental health treatment services. If successful, the app scope could be extended beyond veterans and to other populations and difficulties. Clinical Trial: N/a


 Citation

Please cite as:

Hitch C, Leightley D, Murphy D, Dymond S

ACT Vet: A mixed-methods pilot study of efficacy, usability and cost-effectiveness of an Acceptance and Commitment Therapy (ACT) based app for veterans with harmful gambling and PTSD

JMIR Preprints. 24/10/2023:53924

DOI: 10.2196/preprints.53924

URL: https://preprints.jmir.org/preprint/53924

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.